DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Torrent Pharmaceuticals Limited — Acquisition

NSE 1 hr ago·28 Sept 2026, 6:33 am

Torrent Pharmaceuticals

Torrent Pharmaceuticals has informed stock exchanges that it is acquiring a business or stake, complying with SEBI disclosure norms. This move signals a strategic expansion for the company.

For investors, such an acquisition typically indicates management's intent to grow revenue or enter new markets. It can be a positive signal if the target business aligns well with Torrent's existing portfolio and operations.

Investors should watch for details on the deal's value and the specific business being acquired. Monitoring the company's future financial performance will be key to understanding the long-term impact of this expansion.